DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

India Glycols hosts Q1FY27 earnings call on Aug 14

scanx.trade 12 hrs ago·6 Aug 2026, 11:40 am

India Glycols is set to host its first-quarter earnings call for fiscal year 2027 on August 14. This is a key event for investors to review the company's financial performance and strategic outlook for the upcoming year.

The earnings call will provide insights into India Glycols' operational efficiency, sales growth, and cost management. Investors should pay close attention to management commentary on market conditions and future expansion plans to gauge the company's trajectory.

For retail investors, this is a valuable opportunity to understand the company's current standing and potential for growth. Following the call, analysts will likely update their price targets, making this a crucial time to stay informed about the stock's performance.